tirzepatide cos è Tirzepatide: il nuovo farmaco per diabete e obesità arriva in Italia Tirzepatide: di Cosa si Tratta?

Clinical trials show Ozempic works well to help control glucose levels

The pharmaceutical industry is focusing on critical preparation areas to ensure successful market entry once patents expire, with supply chain security emerging as the primary challenge

While Ozempic features the same active ingredient found in many weight loss medications, its sole approval is for managing type 2 diabetes, not for weight loss

Anti-Inflammatory Properties: GLP-1 treatments can help reduce inflammation in the body, promoting overall health and well-being, and providing an additional benefit for those on their weight loss journey

In the completed SURPASS J-combo [28] trial, tirzepatide has shown glycemic control improvement and a reduction in body weight regardless of the patient's underlying medications and is well tolerated as an adjunct to oral antihyperglycemic monotherapy in Japanese patients with T2DM